KalVista Pharmaceuticals, Inc.KALVNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank42
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P42
Within normal range
vs 2Y Ago
-21.5x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
2025-71.00%
2024-17.29%
20233.30%
2022-161.35%
202132.82%
2020-20.27%
2019-510.10%
2018138.37%
2017-80.72%
2016-102.79%